Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 122

    1.

    A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.

    Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA.

    Nicotine Tob Res. 2009 Jul;11(7):859-67. Epub 2009 May 29.PMID: 19483180 [PubMed - indexed for MEDLINE]Related articles

    2.

    Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

    Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

    Clin Ther. 2001 May;23(5):744-52.PMID: 11394732 [PubMed - indexed for MEDLINE]Related articles

    3.

    A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

    Robles GI, Singh-Franco D, Ghin HL.

    Clin Ther. 2008 May;30(5):800-12. Review.PMID: 18555928 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

    Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

    Ann Intern Med. 2001 Sep 18;135(6):423-33.PMID: 11560455 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

    Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

    Addiction. 2004 Sep;99(9):1206-18.PMID: 15317642 [PubMed - indexed for MEDLINE]Related articles

    6.

    Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

    Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.

    JAMA. 2006 Jul 5;296(1):47-55.PMID: 16820546 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

    Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, Rowland KM, Bernath A, Loots ML, Le-Lindqwister NA, Tschetter LK, Garneau SC, Flynn KA, Ebbert LP, Wender DB, Loprinzi CL.

    Mayo Clin Proc. 2007 Feb;82(2):186-95.PMID: 17290726 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

    Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group.

    JAMA. 2006 Jul 5;296(1):56-63. Erratum in: JAMA. 2006 Sep 20;296(11):1355. PMID: 16820547 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.

    Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS.

    JAMA. 2002 Jul 24-31;288(4):468-74.PMID: 12132977 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

    J Clin Psychopharmacol. 2007 Aug;27(4):380-6.PMID: 17632223 [PubMed - indexed for MEDLINE]Related articles

    11.

    Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

    Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

    Ann Intern Med. 2009 Apr 7;150(7):447-54.PMID: 19349630 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.

    Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, Petkova E, Rodriguez K.

    Addiction. 2007 Aug;102(8):1292-302.PMID: 17624979 [PubMed - indexed for MEDLINE]Related articles

    13.

    Varenicline: a first-line treatment option for smoking cessation.

    Garrison GD, Dugan SE.

    Clin Ther. 2009 Mar;31(3):463-91. Review.PMID: 19393839 [PubMed - indexed for MEDLINE]Related articles

    14.

    A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.

    McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB.

    Nicotine Tob Res. 2008 Apr;10(4):717-29.PMID: 18418793 [PubMed - indexed for MEDLINE]Related articles

    15.

    A comparison of sustained-release bupropion and placebo for smoking cessation.

    Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

    N Engl J Med. 1997 Oct 23;337(17):1195-202.PMID: 9337378 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.

    Hurt RD, Patten CA, Offord KP, Croghan IT, Decker PA, Morris RA, Hays JT.

    J Stud Alcohol. 2005 Jul;66(4):506-16.PMID: 16240558 [PubMed - indexed for MEDLINE]Related articles

    17.

    A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.

    Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M.

    J Clin Psychopharmacol. 2008 Dec;28(6):660-6.PMID: 19011435 [PubMed - indexed for MEDLINE]Related articles

    18.

    Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.

    Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, Kardinal CG, Knost JA, Tirona MT, Addo F, Morton RF, Michalak JC, Schaefer PL, Porter PA, Stella PJ.

    J Clin Oncol. 2003 Mar 1;21(5):914-20.PMID: 12610193 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of sustained-release bupropion in specific patient populations for smoking cessation.

    Tonstad S.

    Drugs. 2002;62 Suppl 2:37-43. Review.PMID: 12109934 [PubMed - indexed for MEDLINE]Related articles

    20.

    Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.

    Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B.

    Lancet. 2001 May 19;357(9268):1571-5.PMID: 11377644 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data